Introduction {#s1}
============

*Dendrobium nobile* Lindl, the plant belongs Orchidaceae family, is one of three major plant sources of the traditional Chinese medicine "Shi Hu" in Chinese (edition 2005), which are used as a tonic to nourish the stomach and promote the production of body fluid recorded in the Chinese Pharmacopeia (Jiangsu New Medical College, [@B6]). The previous reports showed a series of chemical constituents isolated from *D. nobile* including sesquiterpenes (Zhang et al., [@B16]), alkaloids (Liu and Zhao, [@B11]; Meng et al., [@B12]), bibenzyls derivatives (Zhang et al., [@B17]), and glucosides (Zhao et al., [@B18]), some of which exhibited antitumor (Zhou et al., [@B20]), anti-inflammatory (Hwang et al., [@B4]), and immunomodulatory activities (Zhao et al., [@B18]).

Picrotoxane-type sesquiterpenes were one of main constituents of *D. nobile*, which exhibited the angiogenesis effect against sunitinibinduced damage (Meng et al., [@B12]) and inhibitory activity of nerve growth factor mediated neurite outgrowth (Leon et al., [@B10]). Our phytochemical investigation on the EtOAc extract of the stems of *D. nobile* led to the isolation of four new picrotoxane-type sesquiterpenes, dendroterpene A--D (**1**--**4**), along with four known compounds, nobilin E (**5**) (Zhang et al., [@B17]), dendrocandin V (**6**) (Xiao et al., [@B15]), *S*(+)-dehydrovomifoliol (**7**) (Kato et al., [@B8]) and di-\[2-(4-hydroxyphenyl)\] ethyl ether (**8**) (Krysin et al., [@B9]). Compounds **1** and **2** are two new picrotoxane-type sesquiterpenes with a new carbon skeleton containing a formamide group, which may be derived from the previously reported dendrobiumane B skeleton by the C(9)-C(11) carbon bond cleavage. In this report, the isolation, structure elucidation and bioactivities of these compounds are described.

Materials and Methods {#s2}
=====================

General Experimental Procedures
-------------------------------

Optical rotations were measured on a MCP 5100 modular compact polarimeter (Anton Paar, America). IR spectra were taken on a Nicolet 380 FT-IR instrument (Thermo, USA) as KBr discs. NMR spectra were recorded on a Bruker Avance III 500 MHz NMR spectrometer (Bruker, German). ESIMS and HRESIMS were recorded with amaZon SL (Bruker) or Compact QqTOF (Bruker). ECD spectra were measured by APL Chiascan (Applied Photophysics Ltd., England). Semi-preparative HPLC was carried out using a C~18~ column (Cosmosil-pack, 10 × 250 mm, 5 μm, 4 mL/min, Nacalai Tesque). C~18~ gel (20--45 μm, Fuji SilysiSa Chemical Co., Ltd., Greenville, NC, UA), Silica gel (60--80, 200--300 mesh, Qingdao Marine Chemical Co., Ltd., Qingdao, China), Sephadex LH-20 (Merck, Kenilworth, NJ, USA) were used for column chromatograghy. α-glycosidase (Sigma-Aldrich, UA) used for the bioactivity was derived from yeast and its EINECS (EC) unmber is 3.2.1.20.

Plant Material and Extraction
-----------------------------

The fresh stems of *D. nobile* were collected from Shishan town in May 2018, Hainan, China. After drying, the dried stems (13.0 kg) were shattered. Then, the samples were extracted by 95% ethyl alcohol three times and for 5 days each time. The EtOH extract (716.2 g) was dissolved in H~2~O and extracted three times by petroleum ether (8.0 L), EtOAc (8.0 L), and n-butyl alcohol (8.0 L) successively.

Isolation
---------

The EtOAc extract (87.9 g) was separated into 16 fractions (Fr.1--Fr.16) by a silica gel column (200--300 mesh) using a gradient of petroleum ether-EtOAc (v/v, 20:1-- 0:1) and then acetone. Fr.9 (10.0 g) was further separated into 20 fractions (Fr.9-1--Fr.9-20) by ODS column. Fr.9-1 (30.0 mg) was purified by semipreparative HPLC (20% MeOH/H~2~O) to yield **8 (**1.4 mg; *t*~R~ 12.1 min). Fr.9-6 (112.0 mg) was purified by semipreparative TLC eluting with petroleum ether-acetone (v/v 3:1) to obtain compound **7** (2.7 mg). Fr.9-7 (372.0 mg) was purified by a silica gel column eluting with petroleum ether-CHCl~3~-MeOH (v/v/v 200:50:1) to yield compound **3** (4.2 mg). Compound **4** (2.0 mg) was obtained by recrystallization from Fr.9-8 (580.3 mg). Fr.9-10 (103.0 mg) was further purified by a silica gel column eluting with petroleum ether-acetone (v/v 8:1) to give **1** (13.0 mg). Fr.10 (9.0 g) was separated by ODS column to get 50 fractions (Fr.10-1--Fr.10-50). Compound **2** (100.2 mg) was obtained by recrystallization from Fr.10-14 (326.0 mg). Fr.10-38 (184.0 mg) was purified by Sephadex LH-20 eluting with MeOH to give **5** (15.0 mg). Fr.11 (9.0 g) was separated into three fractions (Fr.11-1--Fr.11-3) by Sephadex LH-20 eluting with MeOH. Fr.11-3 (80.1 mg) was purified by ODS column eluting with 65% MeOH/H~2~O to yield compound **6** (20.9 mg).

ECD Calculation
---------------

The calculations were performed by using the density functional theory (DFT) as carried out in the Gaussian 03 (Frisch et al., [@B2]). The preliminary conformational distributions search was performed by Sybyl-X 2.0 software. All ground-state geometries were optimized at the B3LYP/6-31G(d) level. Solvent effects of methanol solution were evaluated at the same DFT level by using the SCRF/PCM method (Cammi and Tomasi, [@B1]). TDDFT at B3LYP/6-31G(d) was employed to calculate the electronic excitation energies and rotational strengths in methanol (Gross et al., [@B3]).

Characterization of Compounds 1--4
----------------------------------

Dendroterpene A (**1**): Colorless crystals; \[$\left\lbrack \alpha \right\rbrack_{\text{D}}^{25}$\] +149.9 (*c* 0. 1, MeOH); ECD (MeOH) λ~max~ (Δε) 223 (+2.28); IR (KBr) ν~max~ 3350, 2927, 2856, 1761, 1683, 1118, 1024 cm^−1^; m.p. 185--186 °C; ^1^H and ^13^C NMR (see [Table 1](#T1){ref-type="table"}); HRESIMS *m*/*z* 286.1417 \[M + Na\]^+^ (calcd. for C~15~H~21~NO~3~Na: 286.1414).

###### 

^1^H (500 MHz) and ^13^C (125 MHz) NMR Data of compounds **1**--**4**.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **No**.   **1[^a^](#TN1){ref-type="table-fn"}**   **2[^b^](#TN2){ref-type="table-fn"}**   **3[^c^](#TN3){ref-type="table-fn"}**   **4[^c^](#TN3){ref-type="table-fn"}**                                                          
  --------- --------------------------------------- --------------------------------------- --------------------------------------- --------------------------------------- ------------- -------------------------- ------------- ----------------------
  1         52.5, C                                 --                                      53.3, C                                 --                                      47.8, C       --                         50.4, C       --

  2         51.2, CH                                4.24, s                                 49.0, CH                                4.18, d, (9.7)                          81.5, CH      4.28,d, (3.6)              81.6, CH      4.25, d, (3.6)

  3         84.5, CH                                4.34, brd, (5.5)                        83.2, CH                                4.33, brd, (5.6)                        77.9, CH      4.75,dd, (3.6, 5.6)        77.5, CH      4.79, dd, (3.6, 5.1)

  4         52.5, CH                                2.02, m                                 52.3, CH                                2.01, ddd, (4.7, 4.7, 11.2)             50.9, CH      2.29,ddd, (5.0,5.0,11.7)   51.1, CH      2.27, m

  5         46.1, CH                                2.28, t, (4.3)                          51.0, CH                                2.47, d, (4.7)                          43.4, CH      2.57, dd, (4.3,5.6)        43.2, CH      2.57, dd, (4.3, 5.8)

  6         42.5, CH                                2.33, m                                 80.6, C                                 --                                      43.6, CH      2.20, m                    44.9, CH      2.31, m

  6-OH      --                                      --                                      --                                      5.40, brs                               --            --                         --            --

  7         36.9, CH~2~                             2.69, ddd,\                             46.1, CH~2~                             2.64, brd, (15.1)\                      32.4, CH~2~   2.15, m                    29.7, CH~2~   2.07, m; 2.36, m
                                                    (2.3, 2.3, 7.3,17.1)\                                                           2.52, brd, (15.1)                                                                              
                                                    2.35, m                                                                                                                                                                        

  8         130.3, CH                               5.51, dd, (2.3, 5.5)                    137.3, CH                               5.79, brd, (6.3)                        27.8, CH~2~   2.01, m; 2.14, m           38.5, CH~2~   1.82, m; 2.28, m

  9         136.6, CH                               5.63, m                                 127.7, CH                               5.47, d, (6.3)                          55.2, CH      2.77,t, (9.4)              85.1, C       --

  10        27.3, CH~3~                             1.04, s                                 22.3, CH~3~                             0.96, s                                 31.3, CH~3~   1.52, s                    24.3, CH~3~   1.43, s

  11        163.7, CH                               8.09, s                                 161.7, CH                               8.12, s                                 177.1, C      --                         177.2, C      --

  12-NH     --                                      --                                      --                                      8.51, d, (9.6)                          --            --                         --            --

  13        26.4, CH                                1.84, m                                 26.4, CH                                2.36, m                                 24.8, CH      1.75, m                    24.8, CH~3~   1.84, m

  14        20.1, CH                                0.95, d, (6.6)                          22.2, CH~3~                             1.00, d, (6.1)                          20.6, CH~3~   1.04, d, (6.5)             20.7, CH~3~   1.04, d, (6.5)

  15        21.0, CH~3~                             0.93, d, (6.6)                          20.3, CH~3~                             0.89, d, (6.6)                          21.4, CH~3~   1.02, d, (6.5)             21.5, CH~3~   1.02, d, (6.6)

  16        180.3, C                                --                                      176.5, C                                --                                      177.5, C      --                         177.5, C      --
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

measured in CD~3~OD;

measured in DMSO-d~6~;

*measured in CDCl~3.~*.

Dendroterpene B (**2**): Colorless crystals; \[$\left\lbrack \alpha \right\rbrack_{\text{D}}^{25}$\] +10.0 (*c* 0.1, MeOH); ECD (MeOH) λ~max~ (Δε) 207 (+4.77); IR (KBr) ν~max~ 3414, 2964,2926, 2861, 1764, 1666, 1223, 1021 cm^−1^; m.p. 200--201°C; ^1^H and ^13^C NMR (see [Table 1](#T1){ref-type="table"}); HRESIMS *m/z* 302.1376 \[M + Na\]^+^ (calcd. for C~15~H~21~NO~4~Na: 302.1363).

Dendroterpene C (**3**): White powder; \[$\left\lbrack \alpha \right\rbrack_{\text{D}}^{25}$\] +16.0 (*c* 0.1, MeOH); ECD (MeOH) λ~max~ (Δε) 225 (+ 1.16), IR (KBr) ν~max~ 3447, 2928, 1777, 11276, 1111, 1036 cm^−1^; ^1^H and ^13^C NMR (see [Table 1](#T1){ref-type="table"}); HRESIMS *m/z* 287.1281 \[M + Na\]^+^ (calcd. for C~15~H~20~O~4~Na:287.1254).

Dendroterpene D (**4**): Colorless crystals; \[$\left\lbrack \alpha \right\rbrack_{\text{D}}^{25}$\] +139.9 (*c* 0.1, MeOH); IR (KBr) ν~max~ 3414, 2930, 1629, 1108, 1028 cm^−1^; m.p. 167--168 °C; ^1^H and ^13^C NMR (see [Table 1](#T1){ref-type="table"}); HRESIMS *m*/*z* 303.1228 \[M + Na\]^+^ (calcd. for C~15~H~20~O~5~ Na: 303.1203).

X-Ray Crystallographic Data of 1, 2, and 4
------------------------------------------

Compound **1** was obtained as colorless crystals with molecular formula of C~15~H~21~NO~3~ from MeOH. Space group *P2*~1~*2*~1~*2*~1~, *a* = 7.7078(5) Å, *b* = 10.1533 (7) Å, *c* = 17.8721(12) Å, α = 90.00°, β = 90.00(10)°, γ = 90.00°, *V* = 1398.66 (16) Å^3^, *Z* = 4, *D*~calcd~ = 1.251 g/cm^3^, μ(CuKα) = 0.7000 mm^−1^, and F(000) = 568, *T* = 293(2) K, crystal size 0.32 × 0.20 × 0.12 mm, *R*~1~ = 0.0445(*I*\>*2sigma(I), wR*~2~ = 0.1054 (all data), Flack parameter = 0.0(4). 3147 reflections measured, 2119 unique (*R*~int~ = 0.0213, *R*~sigma~ = N/A) which were used in all calculations. The structure was solved by direct methods (SHELXS-97) and expanded using Fourier techniques (SHELXL-97). Crystallographic data (excluding structure factors) for structure **1** in this paper have been deposited in the Cambridge Crystallographic Data Center as supplementary publication number CCDC 1943060.

Compound **2** was obtained as colorless crystals with molecular formula of C~15~H~21~NO~4~ from MeOH. Space group *P*2~1~, *a* = 7.7610(4) Å, *b* = 8.8111 (4) Å, *c* = 10.3388(6) Å, α = 90.00°, β = 104.463(5)°, γ = 90.00°, *V* = 684.59 (6) Å^3^, *Z* = 2, *D*~calcd~ = 1.300 g/cm^3^, μ(CuKα) = 0.771 mm^−1^, *F*(000) = 300, crystal size 0.34 × 0.27 × 0.13 mm, *R*~1~ = 0.0390(*I*\>*2sigma(I), wR*~2~ = 0.1028 (all data), Flack parameter = 0.0(4). 3304 reflections measured, 2070 unique (*R*~int~ = 0.0259, *R*~sigma~ = N/A) which were used in all calculations. The structure was solved by direct methods (SHELXS-97) and expanded using Fourier techniques (SHELXL-97). Crystallographic data (excluding structure factors) for structure **2** in this paper have been deposited in the Cambridge Crystallographic Data Center as supplementary publication number CCDC 1943062.

Compound **4** was obtained as colorless crystals with molecular formula of C~15~H~21~NO~3~ from MeOH. Space group *P*2~1~, *a* = 7.5120(3) Å, *b* = 13.6611(7) Å, *c* = 13.9060(5) Å, α = 90.00°, β = 90.00(10)°, γ = 90.00°, *V* = 1427.06(11) Å^3^, *Z* = 4, *D*~calcd~ = 1.360 mg/m^3^, μ(CuKα) = 0.842 mm^−1^, *F*(000) = 600, crystal size 0.327 × 0.22 × 0.15 mm. *R*~1~ = 0.0368(*I*\>*2sigma(I), wR*~2~ = 0.0938 (all data), Flack parameter = 0.1(3). 2227 reflections measured, 1628 unique (*R*~int~ = 0.0204, *R*~sigma~ = N/A) which were used in all calculations. The structure was solved by direct methods (SHELXS-97) and expanded using Fourier techniques (SHELXL-97). Crystallographic data (excluding structure factors) for structure **4** in this paper have been deposited in the Cambridge Crystallographic Data Center as supplementary publication number CCDC 1943065.

Bioassay for α-Glycosidase Inhibitory Activity
----------------------------------------------

The method optimized by Jong et al. ([@B7]) was performed *in vitro* to test the α-glucosidase inhibitory activity of compounds **1**--**8**. Acarbose was used as positive control.

Bioassay for Cytotoxicity
-------------------------

The MTT method optimized by Mosmann ([@B13]) was performed *in vitro* to test the cytotoxic activity of compounds **1**--**8**. Cisplatin was used as a positive control.

Results and Discussion {#s3}
======================

Identification of Compounds 1-4
-------------------------------

Compound **1** was obtained as colorless crystals with the molecular formula as C~15~H~21~NO~3~, which was determined based on the pseudo-molecular ion peak at *m/z* 286.1417 \[M + Na\]^+^ (calcd. for C~15~H~21~NO~3~Na: 286.1414) in the HRESIMS spectrum. Analysis of its 1D and HSQC NMR spectra (see [Supplementary Figures 1](#SM1){ref-type="supplementary-material"}, [2](#SM1){ref-type="supplementary-material"}, and [4](#SM1){ref-type="supplementary-material"} in the Supplementary Material) revealed two olefinic methines (δ~C/H~ 136.6/5.63 and δ~C/H~ 130.3/5.51), three methyls (δ~C/H~ 27.3/1.04, 21.0/0.93 and 20.1/0.95), one methylene (δ~C/H~ 36.9/2.69, 2.35), six sp^3^ methines (δ~C/H~ 84.5/4.34, 52.5/2.02, 51.2/4.24, 46.1/2.28, 42.5/2.33, and 26.4/1.84) with one oxygenated, one quaternary carbon (δ~C~ 52.5) and two ester or amide carbonyl groups (δ~C~ 180.3 and δ~C~ 163.7). The above data and sequential COSY correlations ([Figure 2](#F2){ref-type="fig"} and [Supplementary Figure 3](#SM1){ref-type="supplementary-material"} in the Supplementary Material) from H-2 to H-9, as well as from H-4 to H~3~-14 and H~3~-15 through H-13, along with the HMBC correlations ([Figure 2](#F2){ref-type="fig"} and [Supplementary Figure 5](#SM1){ref-type="supplementary-material"} in the Supplementary Material) from H~3~-10 to C-2, C-6 and C-9, from H-2 to C-6 and C-9, from H-3 and H-6 to C-16, and from H-5 to C-1, revealed a picrotoxane-type sesquiterpene skeleton (Zhao et al., [@B19]). A detailed comparison of the above data with those of the previously reported dendrobiumane C (Zhao et al., [@B19]) disclosed high similarity. The differences between them were that the hydroxymethyl group CH~2~-11 (δ~C/H~ 59.8/4.04, 4.27) and the oxymethine group CH-2 (δ~C/H~ 73.1/3.67) in dendrobiumane C were replaced by a hydrogen atom H-9 (δ~H~ 5.51) and a methine CH-2 (δ~C/H~ 51.2/4.24) linked with a formamide group in **1**, respectively, as evidence by COSY correlation from H-9 to H-8, along with the HMBC correlations from H-2 to C-9 and C-11, from H-9 to C-6 and C-10, as well as from H~3~-10 to C-2 and C-6. The ROESY correlations ([Figure 3](#F3){ref-type="fig"} and [Supplementary Figure 6](#SM1){ref-type="supplementary-material"} in the Supplementary Material) from H~3~-10 to H-2, H-6 and H-13, and from H-2 and H-6 to H-13 suggested that H-2, H-6 and H~3~-10 were on the same face of the six-member ring, while H-4 was on the face opposite to them. Due to the complex bridge-ring lactone skeleton, the chemical structure models analysis of **1** displayed the only possibility of the relative configurations of C-3 and C-5 is that H-3 and H-5 were on the same face of six-member ring with H-2, H-6, and H~3~-10 when the relative configurations of C-1, C-2, C-4 and C-6 were confirmed. To support the above structure elucidation and determine the absolute configuration of **1**, a single-crystal X-ray diffraction pattern was obtained using the anomalous scattering of Cu Kα radiation ([Figure 4](#F4){ref-type="fig"}), allowing an explicit assignment of the absolute configuration of **1** as 1*S*, 2*S*, 3*R*, 4*S*, 5*R*, and 6*S*. In order to confirm the absolute configuration assignment, Lactone sector rule (Jexkings et al., [@B5]) based on ECD data was used. The molecule was viewed from the line on the plane of the ester group along the bisectrix of the O--C = O angle, i.e., as shown in [Figure 5](#F5){ref-type="fig"} for 4*S*. The functional group at C-4 lying in the back upper right sector was responsible for the positive CD Cotton effect resulted from n--π^\*^ transition of lactone, which was well in accordance with the positive Cotton effect at λ~max~ 223 nm of **1** ([Supplementary Figure 24](#SM1){ref-type="supplementary-material"} in Supplementary Material). Hence, compound **1**, named as dendroterpene A, was determined to be a picrotoxane-type sesquiterpene.

![The structures of compounds **1--8**.](fchem-07-00812-g0001){#F1}

![Key HMBC (![](fchem-07-00812-i0001.jpg)) and ^1^H--^1^H COSY (−) correlations of compounds **1**--**4**.](fchem-07-00812-g0002){#F2}

![ROESY (![](fchem-07-00812-i0002.jpg)) correlations of compounds **1**--**3**.](fchem-07-00812-g0003){#F3}

![Molecular plots of compounds **1**, **2**, and **4**.](fchem-07-00812-g0004){#F4}

![Application of lactone sector rule to compounds **1** and **2**.](fchem-07-00812-g0005){#F5}

Compound **2** was also isolated as colorless crystals. The HRESIMS (*m/z* 302.1376 \[M + Na\]^+^, calcd. for C~15~H~21~NO~4~Na: 302.1363) indicated a molecular formula of C~15~H~21~NO~4~. The 1D and 2D NMR data of **2** ([Table 1](#T1){ref-type="table"} and [Figure 2](#F2){ref-type="fig"}) were very similar to those of **1**, except that an oxygenated quaternary carbon C-6 (δ~C~ 80.6) in **2** replaced signals corresponding to CH-6 in **1** (δ~C/H~ 42.5/2.33). In the HMBC spectrum ([Figure 2](#F2){ref-type="fig"} and [Supplementary Figure 11](#SM1){ref-type="supplementary-material"} in the Supplementary Material) of **2**, correlations from H-2, H-4, H-8, H-9, 6-OH, and H~3~-10 to the oxygenated quaternary carbon C-6, together with the molecular formula, suggested that the H-6 in **1** was oxygenated to a hydroxylated quaternary carbon in **2**. The H-2, 6-OH and H~3~-10 were on the same face of the six-member ring, and the H-4 was on the opposite face in **2**, as evidence by the ROESY correlations ([Figure 3](#F3){ref-type="fig"} and [Supplementary Figure 12](#SM1){ref-type="supplementary-material"} in the Supplementary Material) of H~3~-10 with H-2, H-13 and 6-OH, and of H-2 and 6-OH with H-13. The relative configurations of C-3 and C-5 in **2** were identical with those of **1** according to the chemical structure models analysis of **2**.

The above assignment was further confirmed by a single-crystal X-ray diffraction pattern obtained using the anomalous scattering of Cu Kα radiation ([Figure 4](#F4){ref-type="fig"}), which also led to an unambiguous assignment of the absolute configuration of **2** as 1*R*, 2*S*, 3*R*, 4*S*, 5*S*, and 6*R*. The absolute configuration of **2** was also confirmed by Lactone sector rule based on ECD data (Jexkings et al., [@B5]) ([Figure 5](#F5){ref-type="fig"} and [Supplementary Figure 24](#SM1){ref-type="supplementary-material"} in Supplementary Material). Therefore, compound **2** was also identified as a picrotoxane-type sesquiterpene, and named as dendroterpene B.

Compound **3** has the molecular formula of C~15~H~20~O~4~ based on HRESIMS (*m/z* 287.1281 \[M + Na\]^+^, calcd for C~15~H~20~O~4~Na:287.1254), suggesting six degrees of unsaturation. 1D NMR and HSQC data displayed three methyls (δ~C/H~ 31.3/1.52, 21.4/1.02 and 20.6/1.04), two methylenes, seven methines including two oxygenated ones (δ~C/H~ 81.5/4.28 and 77.9/4.75), three quaternary carbons including two ester carbonyl carbons (δ~C~ 177.5 and 177.1). The above data of **3** were very similar to those of the previously reported dedrobiumane E (Zhao et al., [@B19]). Their structural differences were that two oxygenated quaternary carbons C-6 (δ~C~ 76.8) and C-9 (δ~C~ 83.8) and two oxygenated methine groups CH-7 (δ~C/H~ 65.2/4.05) and CH-8 (δ~C/H~ 60.1/3.86) in dedrobiumane E were replaced by two sp^3^ methines (δ~C/H~ 43.6/2.20 and δ~C/H~ 55.2/2.77) and two sp^3^ methylenes (δ~C/H~ 32.4/2.15 and δ~C/H~ 27.8/2.01, 2.14) in **3**, as proved by the sequential COSY correlations of H-5/H-6/H-7/H-8/H-9, along with the detail interpretation of the HMBC correlations from H-2 to C-6, C-9, and C-11, from H~3~-10 to C-2, C-6, and C-9, from H-3 and H-6 to C-16, from H-5 to C-1, as well as from H-8 to C-11 ([Figure 2](#F2){ref-type="fig"}). The ROESY experiments ([Figure 3](#F3){ref-type="fig"} and [Supplementary Figure 18](#SM1){ref-type="supplementary-material"} in the Supplementary Material) displayed the correlations from H~3~-10 to H-2, H-6, and H-9, as well as the correlations between H-2 and H-13, indicating H-2, H-6, H-9, and H~3~-10 were on the same face, while H-4 was on the face opposite to them. The relative configurations of C-3 and C-5 in **3** were also determined to be consistent with those of **1** and **2** through the same method. The calculated ECD curve for **3** matched well with the experimental one ([Figure 6](#F6){ref-type="fig"}), assigning the absolute configurations of **3** as 1*R*, 2*S*, 3*R*, 4*S*, 5*R*, 6*S*, and 9*S* (Wang et al., [@B14]). Thus, the structure of **3** was established as picrotoxane-type sesquiterpene shown in [Figure 1](#F1){ref-type="fig"}, and named as dendroterpene C.

![Measured ECD and TD-DFT calculated ECD curves of compound **3**.](fchem-07-00812-g0006){#F6}

Compound **4**, colorless crystals, the molecular formula of which was established to be C~15~H~20~O~5~ according to the pseudo-molecular ion peak at *m/z* 303.1228 \[M + Na\]^+^ (calcd. for C~15~H~20~O~5~Na: 303.1203) in the HRESIMS spectrum. The similarity of NMR data ([Table 1](#T1){ref-type="table"} and [Figure 2](#F2){ref-type="fig"}) between **3** and **4** indicated that they have the same picrotoxane-type sesquiterpene skeleton. The only structural difference between them was CH-9 (δ~C/H~ 55.2/2.77) in **3** was oxygenated to a hydroxylated quaternary carbon (δ~C~ 85.1) in **4**, as supported by sequential COSY correlations of H-2/H-3/H-4/H-5/H-6/H-7/H-8, together with the HMBC correlations from H-2, H-6, H-7, and H~3~-10 to C-9. The stereochemical structure of **4** (1*S*, 2*S*, 3*R*, 4*S*, 5*R*, 6*S*, and 9*R*), was determined by a single-crystal X-ray diffraction pattern obtained using the anomalous scattering of Cu Kα radiation ([Figure 4](#F4){ref-type="fig"}). From a biosynthetic consideration, the absolute configurations of **4** were deduced be identical to those of **1**-**3**. Hence, compound **4** was also identified as a picrotoxane sesquiterpene as shown in [Figure 1](#F1){ref-type="fig"}, named as dendroterpene D.

The Postulated Biosynthesis Pathway of Compounds 1--4
-----------------------------------------------------

The carbon skeletons of previously reported picrotoxane-type sesquiterpenes are highly conserved.

The main skeletal changes are that one is the C-11-O-C-2 ring or the C-11-N-C-2 ring closure exemplified by dendrobiumane E and the other is the C-11-O-C-2 ring or the C-11-N-C-2 ring opening illustrated by dedrobiumane B. In our present study, the discovery of **1** and **2** with a new carbon skeleton containing a formamide group, which was derived from unprecedented carbon bond cleavage pattern prompted us to study its plausible biosynthetic pathways ([Figure 7](#F7){ref-type="fig"}). Dendrobiumane B was assumed to be the biosynthetic precursor of **1**--**4**. Dendrobiumane **B** underwent oxidation to produce the intermediate (**A**). **A** underwent esterification and the C-11-O-C-2 ring closure produced compound **3**, which underwent oxidation to afford compound **4**. Dendrobiumane **B** underwent transamination to give the intermediate (**B**), which underwent oxidation to form intermediate (**C**). **C** underwent cyclization to produce intermediate (**D**), and **D** underwent dehydration to yield intermediate (**E**). **E** underwent oxidation to give intermediate (**F**), which underwent reduction and dehydration to produce compound **1**. Then, **1** underwent oxidation to get **2**.

![Hypothetical biogenetic pathway of compounds **1**--**4**.](fchem-07-00812-g0007){#F7}

Biological Activity
-------------------

Compounds **1**--**8** were tested for inhibitory activity against α-glycosidase using the PNPG method and for cytotoxic effects on SGC-7901, K562, A549, BEL-7402, and Hela cell lines using the MTT method (See [Supplementary Table 1](#SM1){ref-type="supplementary-material"} in the Supplementary Material). The result showed that compounds **3**, **5**, **6**, and **8** exhibited potent inhibitory activity against α-glycosidase with IC~50~ values of 0.97, 0.03, 0.68, and 0.30 mM, respectively (Acarbose as positive control with IC~50~ value of 0.72 mM). Compound **5** displayed weak cytotoxic effects against SGC-7901, K562, A549, BEL-7402, and Hela cell lines with the IC~50~ values of 17.30, 10.39, 29.03, 20.13, and 22.19 μM, respectively (Cisplatin as positive control with IC~50~ values of 4.11, 3.08, 1.93, 4.02, and 11.29 μM), in addition, compound **6** showed cytotoxic effects against K562 with the IC~50~ value of 28.23 μM.

Conclusions {#s4}
===========

In conclusion, four new picrotoxane-type sesquiterpenes (**1**--**4**), together with four known compounds (**5**--**8**), were isolated from the stems of *D. nobile*. Compounds **1** and **2** are two new picrotoxane-type sesquiterpenes with a new carbon skeleton containing a formamide group, which may be derived from the previously reported dendrobiumane B skeleton by the C(9)-C(11) carbon bond cleavage. In the previously report, picrotoxane sesquiterpenes exhibited the angiogenesis effect against sunitinibinduced damage (Meng et al., [@B12]) and inhibitory activity of nerve growth factor mediated neurite outgrowth (Leon et al., [@B10]). Compound **3** exhibited inhibitory activity against α-glycosidase with IC~50~ values of 0.97 mM. However, compound **4** is inactive (IC~50~ \> 1 mM) against α-glycosidase, indicating that the hydroxyl at C-9 may reduce the activity. In addition, the known bibenzyl derivative nobilin E (**5**) exhibited inhibitory effects on NO production in activated murine macrophage-like cell line RAW 264.7 in the previously report (Zhang et al., [@B17]). The bioactivities of the known bibenzyl derivative dendrocandin V (**6**) have not been reported. In this report, compounds **5** and **6** both exhibited inhibitory activity against α-glycosidase with IC~50~ values of 0.03 and 0.68 mM, respectively. In addition, Compound **5** displayed weak cytotoxic effects against SGC-7901, K562, A549, BEL-7402 and Hela cell lines with the IC~50~ values of 17.30, 10.39, 29.03, 20.13, and 22.19 μM, respectively. Compound **6** showed cytotoxic effect against K562 with the IC~50~ value of 28.23 μM.
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